Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-06-25

Clinical Trial Update: Administration of High Doses of Antiretroviral Drugs to Eliminate the Latent HIV-1 Reservoir [Phase 2]

View source ↗

Summary

Phase 2 clinical trial investigating high-dose antiretroviral therapy to eradicate latent HIV-1 reservoirs. The study is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Fundacion para la Investigacion Biomedica del Hospital Universitario Ramon y Cajal | Conditions: HIV-1-infection | Phase 2 | Status: RECRUITING